Naoyuki Koizumi Selected Research

(2- cyclohexy- 6- hydroxybenzo(b)thien- 3- yl)(4- (2- (1- piperidinyl)ethoxy)phenyl) methanone hydrochloride

1/2003

Effects of the novel orally active antiestrogen TZE-5323 on experimental endometriosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoyuki Koizumi Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 02/2004 - 11/2003
1	Neoplasms (Cancer) 02/2004
1	Endometriosis 01/2003
1	Biliary Fistula 02/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 02/2004 - 02/2002
2	Steryl-Sulfatase (Steroid Sulfatase)IBA 02/2004 - 11/2003
2	Estrogens (Estrogen)FDA Link 02/2004 - 01/2003
2	2',4'-dicyanobiphenyl-4-O-sulfamateIBA 02/2004 - 11/2003
1	estrone sulfate (Evex)FDA Link 02/2004
1	EnzymesIBA 02/2004
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2004
1	Estrone FDA Link 02/2004
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 02/2004
1	Leuprolide (Lupron)FDA LinkGeneric 01/2003
1	(2- cyclohexy- 6- hydroxybenzo(b)thien- 3- yl)(4- (2- (1- piperidinyl)ethoxy)phenyl) methanone hydrochlorideIBA 01/2003
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2003
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2003
1	Danazol (Azol)FDA LinkGeneric 01/2003
1	Acetates (Acetic Acid Esters)FDA Link 01/2003
1	Androgen Antagonists (Antiandrogens)IBA 02/2002
1	osaterone acetateIBA 02/2002

Therapy/Procedure

1	Therapeutics 11/2003
1	Intravenous Administration 02/2002